CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer

doi:10.3748/wjg.v18.i18.2253

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6853)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

590

HTML

5620

Figures (1-4)

402

Tables (1-2)

241

Sum=6853

May 14, 2012 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (53)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 14, 2012; 18(18): 2253-2261
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2253

Full Size Figure Download Figure

Figure 4 Migration inhibitory factor binds to CD74 and toll-like receptor 4 on gastric epithelial cells. r-Migration inhibitory factor (MIF) was mixed with MKN-45 cell lysates and immunoprecipitated with anti-MIF with bound cell proteins. Western blotting analysis with anti-CD74 and anti-toll-like receptor 4 (TLR4). MKN-45 lysates were run as a control in the right lane, and MKN-45 cell lysates immunoprecipitated with isotype control antibody were run in the left lane.

Citation: Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer. World J Gastroenterol 2012; 18(18): 2253-2261
URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2253.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2253